The last 10 to 15 years has seen important advances in the management of advanced renal-cell cancer. Laura Wood, RN, MSN, OCN; Megan Price, MSN, APRN, FNP-C; and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss how real-world efficacy and safety data influence the conversations they have with their patients with advanced renal-cell carcinoma regarding treatment options.
Video Library —September 24, 2021
Categories:
Interview with the InnovatorsCleveland Clinic Taussig Cancer Center
Cleveland, OH
Cleveland, OH
Baylor Charles A. Sammons Cancer Center
Dallas, TX
Dallas, TX
Beth Israel Deaconess Medical Center, Harvard Medical School Teaching Hospital, Boston, MA
Last modified: August 10, 2023